[DPHARMA] QoQ Annualized Quarter Result on 30-Jun-2024 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 4.62%
YoY- -9.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 822,584 771,872 704,727 716,301 735,982 801,900 696,717 11.71%
PBT 84,122 80,404 63,267 74,977 89,610 113,168 84,851 -0.57%
Tax -20,190 -19,296 -10,622 -16,120 -19,266 -22,636 -14,739 23.36%
NP 63,932 61,108 52,645 58,857 70,344 90,532 70,112 -5.97%
-
NP to SH 63,932 61,108 52,645 58,857 70,344 90,532 70,112 -5.97%
-
Tax Rate 24.00% 24.00% 16.79% 21.50% 21.50% 20.00% 17.37% -
Total Cost 758,652 710,764 652,082 657,444 665,638 711,368 626,605 13.60%
-
Net Worth 692,598 682,979 682,979 673,359 670,448 666,567 657,045 3.57%
Dividend
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Div 19,238 - 22,124 6,412 9,577 - 21,901 -8.28%
Div Payout % 30.09% - 42.03% 10.90% 13.62% - 31.24% -
Equity
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Net Worth 692,598 682,979 682,979 673,359 670,448 666,567 657,045 3.57%
NOSH 961,942 961,942 961,942 961,942 961,942 952,239 952,239 0.67%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 7.77% 7.92% 7.47% 8.22% 9.56% 11.29% 10.06% -
ROE 9.23% 8.95% 7.71% 8.74% 10.49% 13.58% 10.67% -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 85.51 80.24 73.26 74.46 76.84 84.21 73.17 10.95%
EPS 6.64 6.36 5.49 6.15 7.36 9.52 7.39 -6.89%
DPS 2.00 0.00 2.30 0.67 1.00 0.00 2.30 -8.90%
NAPS 0.72 0.71 0.71 0.70 0.70 0.70 0.69 2.88%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 85.51 80.24 73.26 74.46 76.51 83.36 72.43 11.71%
EPS 6.64 6.36 5.49 6.15 7.31 9.41 7.29 -6.04%
DPS 2.00 0.00 2.30 0.67 1.00 0.00 2.28 -8.37%
NAPS 0.72 0.71 0.71 0.70 0.697 0.6929 0.683 3.58%
Price Multiplier on Financial Quarter End Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 -
Price 1.26 1.20 1.26 1.20 1.30 1.56 1.61 -
P/RPS 1.47 1.50 1.72 1.61 1.69 1.85 2.20 -23.58%
P/EPS 18.96 18.89 23.02 19.61 17.70 16.41 21.87 -9.08%
EY 5.27 5.29 4.34 5.10 5.65 6.09 4.57 9.97%
DY 1.59 0.00 1.83 0.56 0.77 0.00 1.43 7.33%
P/NAPS 1.75 1.69 1.77 1.71 1.86 2.23 2.33 -17.38%
Price Multiplier on Announcement Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 15/08/24 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 23/02/23 -
Price 1.17 1.26 1.21 1.22 1.19 1.44 1.65 -
P/RPS 1.37 1.57 1.65 1.64 1.55 1.71 2.26 -28.39%
P/EPS 17.60 19.83 22.11 19.94 16.20 15.15 22.41 -14.88%
EY 5.68 5.04 4.52 5.02 6.17 6.60 4.46 17.50%
DY 1.71 0.00 1.90 0.55 0.84 0.00 1.39 14.82%
P/NAPS 1.62 1.77 1.70 1.74 1.70 2.06 2.39 -22.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment